---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-019080"
form_type: "8-K"
ticker: "NSPR"
cik: "0001433607"
company_name: "InspireMD, Inc."
filed_at: "2024-05-14T23:59:59+00:00"
generated_at: "2026-06-02T00:39:10.135217+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# InspireMD Q1 revenue up 22% to $1.51M; net loss widens to $7.0M ($0.21/sh)

## Summary
- Revenue $1.51M (+22% YoY); stent units sold 2,553 (+25.6% YoY).
- Net loss $7.03M ($0.21/sh) vs $4.26M ($0.53/sh) in Q1 2023; operating expenses $7.71M (+62%).
- Gross margin fell to 19.4% from 30.1% due to higher training costs.
- Cash $34.0M; one-year C-GUARDIANS results to be presented at LINC 2024.
- CE Mark recertified under MDR; Pete Ligotti appointed EVP/GM North America.

## SEC filing metadata
- accession: 0001493152-24-019080
- form_type: 8-K
- ticker: NSPR
- cik: 0001433607
- company_name: InspireMD, Inc.
- filed_at: 2024-05-14T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1433607/000149315224019080/0001493152-24-019080-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1433607/000149315224019080/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-019080
- JSON: https://secwatch.observer/filing/0001493152-24-019080.json
- Plain text: https://secwatch.observer/filing/0001493152-24-019080.txt

## Key facts
- Earnings Releases
  InspireMD, Inc. reported first quarter ended March 31, 2024 results: revenue $1,511,000, net income $7,032,000, EPS $0.21 per basic and diluted share.
  - Period: first quarter ended March 31, 2024
  - Revenue: $1,511,000
  - Net income: $7,032,000
  - EPS: $0.21 per basic and diluted share
  - Result: reported results
  source text: For the first quarter of 2024, total revenue increased 22.0%, to $1,511,000, from $1,239,000 during the first quarter of 2023. This increase was predominantly driven by growth in existing markets . Gross profit for the first quarter of 2024 decreased by $81,000, or 21.6%, to $292,000, compared to a gross profit of $373,000 for the first quarter of 2023. This decrease resulted primarily from higher training costs of new hires to build capacity for anticipated increased volume requirements . Gross margin (gross profit as a percentage of revenue) decreased to 19.4% during the three months ended March 31, 2024, from 30.1% during the three months ended March 31, 2023. Total operating expenses for the first quarter of 2024 were $7,706,000, an increase of $2,952,000, or 62.1% compared to $4,754,000 for the first quarter of 2023. This increase was primarily due to higher share-based compensation resulting from the recognition of grants made during the second quarter of 2023 and the first quart
  evidence_url: https://www.sec.gov/Archives/edgar/data/1433607/000149315224019080/0001493152-24-019080-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.